• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BD INFUSION THERAPY SYSTEMS INC. S.A. DE C.V. BD Q-SYTE¿ EXTENSION SET; INTRAVASCULAR ADMINISTRATION SET

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BD INFUSION THERAPY SYSTEMS INC. S.A. DE C.V. BD Q-SYTE¿ EXTENSION SET; INTRAVASCULAR ADMINISTRATION SET Back to Search Results
Model Number 385101
Medical Device Problem Codes Break (1069); Leak/Splash (1354)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 03/29/2022
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
Date of event: unknown.The date received by manufacturer has been used for this field.A device evaluation is anticipated but has not yet begun.Upon completion of the investigation, a supplemental report will be filed.
 
Event or Problem Description
It was reported that the bd q-syte¿ extension set tube was broken and leaked blood.The following information was provided by the initial reporter: "tube broken, blood leakage.".
 
Event or Problem Description
It was reported that the bd q-syte¿ extension set tube was broken and leaked blood.The following information was provided by the initial reporter: "tube broken, blood leakage".
 
Additional Manufacturer Narrative
H.6.Investigation summary: a device history record review was completed for provided material number 385101 and lot number 1113054.The review did not reveal any detected abnormalities during the production process that could have contributed to the reported defect and all quality tests were found to be within specification.To aid in the investigation of this issue, the affected sample was returned for evaluation by our quality engineer team.Through inspection of the sample, a crack was observed on the female connector component of the extension.Within our production process, this type of defect cannot be replicated; therefore, we believe this defect could be attributed to the raw material used for the product manufacture or due to customer handling.Further action has not been determined necessary at this time.Our quality team will continue to closely monitor the manufacturing process for signs of this potential defect and any emerging trends.H3 other text : see h.10.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD Q-SYTE¿ EXTENSION SET
Common Device Name
INTRAVASCULAR ADMINISTRATION SET
Manufacturer (Section D)
BD INFUSION THERAPY SYSTEMS INC. S.A. DE C.V.
periferico luis donaldo
colosio no. 579
nogales
MX 
Manufacturer (Section G)
BD INFUSION THERAPY SYSTEMS INC. S.A. DE C.V.
periferico luis donaldo
colosio no. 579
nogales
MX  
Manufacturer Contact
phillip emmert
9450 south state street
sandy, UT 84070
8015296192
MDR Report Key14159728
Report Number9610847-2022-00147
Device Sequence Number2847682
Product Code FPA
UDI-Device Identifier30382903851011
UDI-Public30382903851011
Combination Product (Y/N)N
Initial Reporter CountryTW
PMA/510(K) Number
K142527
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Other,Foreign,User Facility
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date (Section B) 05/04/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Other
Device Expiration Date03/31/2026
Device Model Number385101
Device Catalogue Number385101
Device Lot Number1113054
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer04/13/2022
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 03/29/2022
Supplement Date Received by Manufacturer05/04/2022
Initial Report FDA Received Date04/20/2022
Supplement Report FDA Received Date05/25/2022
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured05/06/2021
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Patient SexUnknown
-
-